FrancophonIA/ELRC3.0 huggingface dataset:
English: Therefore, concomitant use should be avoided, unless the potential benefit to the patient outweighs the risk of systemic corticosteroid side effects.
Estonian: Seetõttu tuleb kooskasutamist vältida, v.a juhul, kui potentsiaalne kasu patsiendile ületab kortikosteroidi süsteemsete kõrvaltoimete tekkeriski.
English: Hypersensitivity reactions with the following
Estonian: Ülitundlikkusreaktsioonid, mis avalduvad järgmiselt:
English: Both hoarseness and the incidence of candidiasis of the mouth and throat may be relieved by rinsing the mouth with water and spitting the water out and/or brushing the teeth after using the product.
Estonian: Nii häälekähedust kui ka suu ja kõri kandidiaasi saab leevendada ravimi võtmise järgselt suu veega loputamise ja vee väljasülitamise ja/või hammaste pesuga.
English: The lowest effective dose of fluticasone propionate needed to maintain adequate asthma control should be used in the treatment of pregnant women.
Estonian: Rasedate ravis tuleb kasutada madalaimat efektiivset flutikasoonpropionaadi annust, millega saab astmat piisavalt kontrolli all hoida.
English: The dose of inhaled corticosteroid should always be reduced to the lowest dose at which effective control of asthma is maintained.
Estonian: Inhaleeritava kortikosteroidi annus peab alati olema langetatud madalaima efektiivse annuseni, millega on võimalik astmat jätkuvalt
English: Systemic effects may occur with any inhaled corticosteroid, particularly at high doses prescribed for long periods.
Estonian: Inhaleeritavad kortikosteroidid võivad põhjustada süsteemseid toimeid, eriti kui tegu on suurte ja pikaajaliseks kasutamiseks määratud annustega.
English: Studies SCO40043 and SCO100250 were randomised, double-blind, parallel-group, replicate studies comparing the effect of salmeterol/fluticasone propionate 50/250 micrograms twice daily (a dose not licensed for COPD treatment in the European Union) with salmeterol 50 micrograms twice daily, on the annual rate of moderate/severe exacerbations in subjects with COPD with FEV1 less than 50% predicted and a history of exacerbations.
Estonian: SCO40043 ja SCO100250 olid randomiseeritud topeltpimedad paralleelrühmadega korratavusuuringud, kus võrreldi salmeterooli/flutikasoonpropionaadi annuse 50/250 mikrogrammi kaks korda ööpäevas (annus ei ole Euroopa Liidus KOK-i raviks litsentseeritud) toimet KOK-i mõõdukatele/rasketele ägenemistele aasta jooksul võrreldes salmeterooliga annuses 50 mikrogrammi kaks korda ööpäevas osalejatel, kelle FEV1 on alla 50% prognoositud normist ja kellel on anamneesis KOK-i ägenemine.
English: Number of primary endpoint events /number of patients
Estonian: Teisese tulemusnäitaja juhtude arv /
English: In the subset of steroid naive asthmatics the time to an individual well controlled week was 16 days in the salmeterol/fluticasone propionate treatment compared with 23 days following treatment with ICS.
Estonian: Varem steroidravi mittesaanud astmahaigete allrühmas oli aeg individuaalse hea kontrolliga nädalani salmeterooli/flutikasoonpropionaadi kasutajatel 16 päeva ja inhaleeritava kortikosteroidi kasutajatel 23 päeva.
English: Do not stop or suddenly reduce your dose of Aerivio Spiromax.
Estonian: Ärge lõpetage Aerivio Spiromax'i kasutamist ega muutke äkitselt Aerivio Spiromax'i annust.
English: Aerivio Spiromax is not indicated for use in children, 12 years of age and younger or adolescents, 13 to 17 years of age.
Estonian: Aerivio Spiromax ei ole näidustatud kasutamiseks 12-aastastel ja noorematel lastel ega noorukitel vanuses 13...17 eluaastat.
English: There is no incidence of additional adverse events following concurrent administration of the two active substances.
Estonian: Kahe toimeaine koosmanustamise järgselt muid lisakõrvaltoimeid ei ole esinenud.
English: Patients should not be initiated on Aerivio Spiromax during an exacerbation, or if they have significantly worsening or acutely deteriorating asthma.
Estonian: Patsiendid ei tohi kasutada Aerivio Spiromax'i astma ägenemise ega märkimisväärselt süvenenud või kiirelt
English: Patients should be advised to have their inhaler to be used for relief in an acute asthma attack available at all times.
Estonian: Patsientidele tuleb soovitada hoida ägedate astmahoogude leevendamiseks ettenähtud inhalaator alati käepärast.
English: To reduce the chance of side effects your doctor will prescribe the lowest dose of this combination of drugs to control your
Estonian: Kõrvaltoimete tekkeriski vähendamiseks määrab arst teile selle ravimikombinatsiooni madalaima annuse, millega saab teie astmat või KOK-i kontrolli all hoida.
English: - if you are allergic (hypersensitive) to salmeterol, fluticasone propionate or any of the other ingredients of this medicine (listed in section 6).
Estonian: Mida on vaja teada enne Aerivio Spiromax'i kasutamist Ärge kasutage Aerivio Spiromax'i: - kui olete salmeterooli, flutikasoonpropionaadi või selle ravimi mis tahes koostisosade (loetletud lõigus 6) suhtes allergiline (ülitundlik).
English: Your doctor will help you to manage your asthma and will adjust the dose of this medicine to the lowest dose that controls your asthma.
Estonian: Arst aitab teil astmat kontrolli all hoida ja kohandab ravimiannust madalaimale astma kontrolliks tõhusale annusele.
English: There is likely to be a similar risk of interaction with other potent CYP3A4 inhibitors (e.g. itraconazole, telithromycin, ritonavir).
Estonian: Muude tugevate CYP3A4 inhibiitoritega (nt itrakonasool, telitromütsiin, ritonaviir) kaasneb tõenäoliselt samasugune koostoimete risk.
English: Route of administration: Inhalation use
Estonian: Manustamistee: inhalatsioon
English: Aerivio Spiromax should be discontinued immediately, the patient assessed and alternative
Estonian: Aerivio Spiromax'i kasutamine tuleb viivitamatult lõpetada, patsiendi seisundit tuleb hinnata ja vajadusel alustada alternatiivravi.
English: • The dose indicator on the rear of the device tells you how many doses (inhalations) are left in your inhaler, starting with 60 inhalations when it is full.
Estonian: • Seadme tagaküljel asuva annusenäidiku abil saate kontrollida, palju annuseid (inhalatsioone) on teie inhalaatorisse alles jäänud.
English: • Increased number of colds have been reported in patients with chronic obstructive pulmonary disease
Estonian: • Kroonilise obstruktiivse kopsuhaigusega (KOK) patsientidel on teatatud külmetushaiguste sagenemisest.
English: Symptomatic mouth and throat candidiasis can be treated with topical antifungal therapy whilst still continuing with Aerivio Spiromax.
Estonian: Suu ja kõri sümptomaatilist kandidiaasi saab ravida paikse seenevastase raviga, jätkates samal ajal Aerivio Spiromax'i võtmist.
English: Tell your doctor if you are taking the following medicines, before starting to use Aerivio Spiromax:
Estonian: Teatage oma arstile enne Aerivio Spiromax'i kasutama hakkamist, kui te võtate järgmiseid ravimeid.
English: Symptomatic candidiasis of the mouth and throat can be treated with topical anti-fungal therapy whilst still continuing with Aerivio Spiromax.
Estonian: Sümptomaatilist suu ja kõri kandidiaasi saab ravida paikse seenevastase raviga, jätkates samal ajal Aerivio
English: Following co-administration, increased incidences of transposed umbilical artery and incomplete ossification of occipital bone were found in rats at doses associated with known glucocorticoid
Estonian: Koosmanustamise järgselt suurenes rottidel nabaväädi väärasetsuse ja kuklaluu mittetäieliku luustumise esinemissagedus selliste annuste juures, mis on seotud teadaolevate glükokortikosteroididest tingitud arenguhäiretega.
English: The concomitant administration of ketoconazole should be avoided, unless the benefits outweigh the potentially increased risk of systemic effects of salmeterol treatment.
Estonian: Ketokonasooli samaaegset manustamist tuleb vältida, v.a juhul, kui kasu ületab salmeteroolravist tingitud süsteemsete toimete potentsiaalselt suurenenud tekkeriski.
English: Behavioural changes, including psychomotor hyperactivity and irritability (predominantly in
Estonian: Käitumishäired, sh psühhomotoorne hüperaktiivsus ja
English: The data presented below refer to a lower dose of the fixed-dose combination containing these two actives, a dose and strength which is not available for Aerivio Spiromax.
Estonian: Järgnevalt esitatud andmed viitavad nende kahe toimeaine fikseeritud annuste kombinatsiooni väiksemale annusele.
English: FOIL
Estonian: FOOLIUM
English: Detailed information on this medicine is available on the European Medicines Agency web site:
Estonian: Täpne teave selle ravimpreparaadi kohta on Euroopa Ravimiameti kodulehel: http://www.ema.europa.eu/.
English: COPD patients with a baseline (pre-bronchodilator) FEV1 <60% of predicted normal were randomised to double-blind medication.
Estonian: Topeltpimemenetlusega ravimi rühma randomiseeriti KOK-iga patsiendid, kelle ravieelne (bronhodilataatori kasutamisele eelnev) FEV1 oli < 60% prognoositud normist.
English: The mouthpiece cover is fixed to your inhaler and must not be taken off. Do not use your inhaler if it is damaged or if the mouthpiece has come apart from your inhaler.
Estonian: Ärge kasutage inhalaatorit, kui see on kahjustatud või kui huulik on inhalaatori küljest lahti tulnud.
English: Aerivio Spiromax 50 micrograms/500 micrograms
Estonian: Aerivio Spiromax 50 mcg/500 mcg
English: EXP Use within 3 months of removing from foil wrapping.
Estonian: Kõlblik kuni: Kasutada 3 kuu jooksul pärast fooliumpakendi eemaldamist.
English: In a 12-week trial of children 4 to 11 years of age [n=203] randomized in a parallel-group study with persistent asthma and who were symptomatic on inhaled corticosteroid, safety was the primary objective.
Estonian: Uuringusse randomiseeriti 4…11 aasta vanused püsiva astmaga lapsed [n = 203], kellel esinesid sümptomid kortikosteroidi inhaleerimisel.
English: There was no significant difference in probability of bone fracture (5.1% placebo, 5.1% salmeterol, 5.4% FP and 6.3% salmeterol/fluticasone propionate; hazard ratio for salmeterol/fluticasone propionate vs placebo: 1.22, 95%
Estonian: Luumurru tekke tõenäosuses olulist erinevust ei leitud (5,1% platseebo, 5,1% salmeterooli, 5,4% flutikasoonpropionaadi ja 6,3% salmeterooli/flutikasoonpropionaadi puhul; riskisuhe salmeterool/flutikasoonpropionaat vs. platseebo: 1,22; 95% usaldusvahemik: 0,87...1,72, p = 0,248).
English: Salmeterol/fluticasone propionate 50/500 N = 1533
Estonian: Salmeterool 50 N = 1521
English: However, animal studies showed no effects of salmeterol or fluticasone
Estonian: Loomuuringutes ei ole täheldatud salmeterooli ega flutikasoonpropionaadi toimet fertiilsusele.
English: Each dose contains approximately 10 milligrams of lactose (as monohydrate).
Estonian: Teadaolevat toimet omav(ad) abiaine(d): Üks annus sisaldab ligikaudu 10 milligrammi laktoosi (monohüdraadina).
English: • Feeling worried (although this effect occurs mainly in children when prescribed this combination of
Estonian: • Murelikkus (ehkki seda esineb peamiselt lastel, kui neile määratakse sama ravimikombinatsiooni, kuid nõrgemates annustes).
English: There are no data available on the use of Aerivio Spiromax in patients with hepatic impairment.
Estonian: Aerivio Spiromax'i kasutamise kohta maksafunktsiooni kahjustusega patsientidel andmed puuduvad.
English: There is no need to adjust the dose in elderly patients or in those with renal impairment.
Estonian: Eakatel ja neerufunktsiooni kahjustusega patsientidel ei ole annuse kohandamine vajalik.
English: The increased incidence of reported pneumonia with salmeterol/fluticasone propionate 50/250 micrograms twice daily appears to be of similar magnitude to the incidence reported following treatment with salmeterol/fluticasone propionate 50/500 micrograms twice daily in TORCH.
Estonian: Pneumoonia või sellega seotud juhtudest teatamise sagedus salmeterooli/flutikasoonpropionaadi (annuses 50/250 mikrogrammi kaks korda ööpäevas) kasutamisel näib sarnanevat uuringu TORCH andmetega, kus salmeterooli/flutikasoonpropionaadi manustati annuses 50/500 mikrogrammi kaks korda ööpäevas.
English: Aerivio Spiromax 50 micrograms/500 micrograms inhalation powder
Estonian: Aerivio Spiromax 50 mikrogrammi/500 mikrogrammi/annuses inhalatsioonipulber
English: Rinsing your mouth out with water and spitting it out immediately and/or brushing your teeth after taking each dose of your medicine may help.
Estonian: Abi võib olla suu veega loputamisest ja vee välja sülitamisest ja/või hammaste pesust kohe pärast iga ravimiannuse võtmist.
English: Key findings from SMART: primary endpoint Patient group
Estonian: Tähtsaimad leiud uuringust SMART: esmane tulemusnäitaja Esmase tulemusnäitaja juhtude arv /
English: Key findings from SMART by inhaled steroid use at baseline: secondary endpoints Number of secondary endpoint
Estonian: Tähtsaimad leiud uuringust SMART inhaleeritavate steroidide ravieelse kasutamise osas: teisesed
English: Each inhaler contains 60 doses and is foil-wrapped.
Estonian: 1 inhalaator sisaldab 60 annust.
English: Keep the mouthpiece cover closed after removal of the foil wrap.
Estonian: Pärast fooliumpakendi eemaldamist hoidke huulikukate suletuna.
English: If you are not getting enough medicine into your lungs, it will not help your
Estonian: Kui teie kopsudesse ei jõua piisavalt ravimit, ei avalda see toimet teie astma või KOK-i vastu nii, nagu peab.
English: Aerivio Spiromax should be used correctly in order to achieve effective treatment.
Estonian: Efektiivse ravitoime tagamiseks tuleb Aerivio Spiromax'i õigesti kasutada.
English: Each metered dose contains 50 micrograms of salmeterol (as salmeterol xinafoate) and 500 micrograms of
Estonian: Üks mõõdetud annus sisaldab 50 mikrogrammi salmeterooli (salmeteroolksinafoaadina) ja 500 mikrogrammi
English: Each delivered dose (the dose that leaves the mouthpiece) contains 45 micrograms of salmeterol (as salmeterol xinafoate) and 465 micrograms of fluticasone propionate.
Estonian: Üks inhaleeritav annus (huulikust saadav annus) sisaldab 45 mikrogrammi salmeterooli (salmeteroolksinafoaadina) ja 465 mikrogrammi flutikasoonpropionaati.
English: If this happens stop using your Aerivio Spiromax inhaler.
Estonian: Sel juhul tuleb Aerivio Spiromax'i inhalaatori kasutamine lõpetada.
English: • A fungal infection in the oesophagus (food canal), which might cause difficulties in swallowing.
Estonian: • Söögitoru seennakkus, mis võib raskendada neelamist.
English: The mean PIFR achieved by patients with asthma or COPD with optimal training (i.e. forceful inhalation) was over 60 L/min, a flow rate at which both devices studied are known to deliver comparable amounts of drug to the lungs.
Estonian: Pärast optimaalset koolitust (s.t tugev sissehingamine) oli astma või KOK-iga patsientide keskmine sissehingamise tippvoolu määr üle 60 l/min.
English: Additional systemic corticosteroid cover should be considered during periods of stress or elective
Estonian: Stressi või plaaniliste operatsioonide korral tuleb kaaluda süsteemsete kortikosteroidide täiendavat manustamist.
English: Aerivio Spiromax is indicated for use in adults aged 18 years and older only.
Estonian: Aerivio Spiromax on näidustatud kasutamiseks ainult 18-aastastel ja vanematel täiskasvanutel.
English: Aerivio Spiromax is for use in patients with severe asthma only.
Estonian: Aerivio Spiromax on kasutamiseks ainult raske astmaga patsientidel.
English: If you use more Aerivio Spiromax than you should
Estonian: Kui te kasutate Aerivio Spiromax'i rohkem kui ette nähtud Inhalaatorit peab kasutama juhiste kohaselt.
English: Open: Hold the Spiromax with the mouthpiece cover at the bottom and open the mouthpiece cover by folding it down until it is fully opened when one click is heard.
Estonian: Avage huulikukate, vajutades allapoole, kuni see on täielikult lahti ja kostub klõpsatus.
English: When to start using a new Aerivio Spiromax
Estonian: Millal tuleb kasutusele võtta uus Aerivio Spiromax
English: Common (may affect up to 1 in 10 people)
Estonian: Sage (võib esineda kuni ühel inimesel 10-st)
English: Parodoxical bronchospasm
Estonian: Respiratoorsed sümptomid (bronhospasm)
English: When it is appropriate to titrate down to a lower strength not available for Aerivio Spiromax, a change to an alternative fixed-dose combination of salmeterol and fluticasone propionate containing a lower dose of the inhaled corticosteroid is
Estonian: Kui annus tuleb tiitrida madalamaks kui saadaolev madalaim Aerivio Spiromax'i annus, tuleb üle minna alternatiivsele, vähem inhaleeritavaid kortikosteroide sisaldavale salmeterooli ja flutikasoonpropionaadi fikseeritud annuste kombinatsioonile.
English: The combination should be avoided unless the benefit outweighs the increased risk of systemic glucocorticoid undesirable effects.
Estonian: Seda kombinatsiooni tuleb vältida, v.a juhul, kui kasu ületab glükokortikoidide süsteemsete kõrvaltoimete suurenenud tekkeriski.
English: Aerivio Spiromax is not available on the market at strengths lower than 50/500 microgram.
Estonian: Aerivio Spiromax'i madalaim turulolev annus on 50/500 mikrogrammi.
English: Your doctor may prescribe an anti-fungal medicine to treat the thrush.
Estonian: Arst võib määrata teile kandidiaasi raviks seenevastast ravimit.
English: An increase in the incidence of pneumonia, including pneumonia requiring hospitalisation, has been observed in patients with COPD receiving inhaled corticosteroids.
Estonian: KOK-iga patsientidel, kes said inhaleeritavaid kortikosteroide, täheldati pneumoonia, sh haiglaravi vajava pneumoonia esinemissageduse suurenemist.
English: Talk to your doctor, pharmacist or nurse before using Aerivio Spiromax if you have:
Estonian: Enne Aerivio Spiromax'i kasutamist pidage nõu oma arsti, apteekri või meditsiiniõega, kui teil on:
English: Due to the fluticasone propionate component, hoarseness and candidiasis (thrush) of the mouth and throat and, rarely, of the oesophagus, can occur in some patients.
Estonian: Flutikasoonpropionaadi sisalduse tõttu ravimis võib mõnedel patsientidel tekkida häälekähedus või suu ja kõri, ja harvadel juhtudel söögitoru kandidiaas.
English: Aerivio Spiromax is for the treatment of patients with severe asthma only.
Estonian: Aerivio Spiromax sobib ainult raske astmaga patsientide ravimiseks.
English: България
Estonian: Polska
English: Aerivio Spiromax should only be used to treat severe asthma in adults aged 18 years and older and
Estonian: Aerivio Spiromax'i võib kasutada raskekujulise astma raviks ainult 18-aastastel ja vanematel täiskasvanutel ning KOK-i põdevatel täiskasvanutel.
English: There were no differences in safety parameters between the two treatment arms.
Estonian: Ohutusnäitajate erinevused kahe ravirühma vahel
English: • Low blood pressure and seizures (fits)
Estonian: • madal vererõhk ja krambihood.
English: Aerivio Spiromax should be administered with caution in patients with active or quiescent pulmonary tuberculosis and fungal, viral or other infections of the airway.
Estonian: Aktiivse või märkamatult kulgeva kopsutuberkuloosi ja seen-, viiruslike või muude hingamisteede infektsioonidega patsientidel tuleb Aerivio Spiromax'i manustamisel olla ettevaatlik.
English: Aerivio Spiromax is indicated in adults 18 years of age and older only.
Estonian: Aerivio Spiromax on näidustatud ainult 18-aastastel ja vanematel täiskasvanutel.
English: If you are breastfeeding, check with your doctor or pharmacist for advice before taking this medicine.
Estonian: Kui te imetate, pidage enne selle ravimi võtmist nõu oma arsti
English: Each metered dose contains 50 micrograms salmeterol (as salmeterol xinafoate) and 500 micrograms fluticasone propionate.
Estonian: Üks mõõdetud annus sisaldab 50 mikrogrammi salmeterooli (salmeteroolksinafoaadina) ja 500 mikrogrammi flutikasoonpropionaati.
English: Rare (may affect up to 1 in 1,000 people)
Estonian: Harv (võib esineda kuni ühel inimesel 1000-st)
English: Place the mouthpiece between the teeth with the lips closed around the mouthpiece, do not bite the mouthpiece of the inhaler.
Estonian: Asetage huulik hammaste vahele, sulgedes huuled ümber huuliku.
English: Medium dose ICS (>500 to 1000 micrograms
Estonian: Inhaleeritav kortikosteroid keskmises annuses (> 500...1000 mikrogrammi kaks korda ööpäevas
English: There was an increased reporting of lower respiratory tract infections (particularly pneumonia and bronchitis) in the TORCH study in patients with COPD receiving salmeterol/fluticasone propionate 50/500 micrograms twice daily compared with placebo as well as in studies SCO40043 and SCO100250 comparing a lower dose of salmeterol/fluticasone propionate 50/250 micrograms twice daily, (a dose not authorised for use in COPD) with salmeterol 50 micrograms twice daily only (see section 4.8 and section 5.1).
Estonian: Sama täheldati ka uuringutes SCO40043 ja SCO100250, kus võrreldi salmeterooli/flutikasoonpropionaadi väiksemat annust 50/250 mikrogrammi kaks korda ööpäevas (mittelubatud annus KOK-i korral) eraldi manustatava salmeterooliga annuses 50 mikrogrammi kaks korda ööpäevas (vt lõik 4.8 ja lõik 5.1).
English: It is important to use the inhaler as instructed.
Estonian: Inhalaatori kasutuseelne raputamine ei ole vajalik.
English: • Tiredness and loss of appetite, feeling sick
Estonian: • väsimus ja isutus, iiveldus;
English: It is recommended to establish the appropriate dosage of inhaled corticosteroid before any fixed-dose combination can be used in patients with severe asthma.
Estonian: Enne seda, kui raske astmaga patsientidel võib hakata kasutama fikseeritud annuste kombinatsiooni, on soovitatav kindlaks määrata inhaleeritava kortikosteroidi asjakohane annus.
English: Serious asthma-related adverse events and exacerbations may occur during treatment with Aerivio Spiromax.
Estonian: Aerivio Spiromax'iga ravimise ajal võivad tekkida tõsised astmaga seotud kõrvaltoimed ja haiguse ägenemine.
English: Due to the fluticasone propionate component, hoarseness and candidiasis (thrush) of the mouth and throat and, rarely of the oesophagus, can occur in some patients.
Estonian: Flutikasoonpropionaadi sisalduse tõttu ravimis võib mõnedel patsientidel tekkida häälekähedus või suu ja kõri ning harva söögitoru kandidiaas.
English: - patients not adequately controlled on a lower strength corticosteroid combination product
Estonian: - patsientidele, kellel väiksemas annuses kortikosteroide sisaldav kombinatsioonravim ei taga piisavat kontrolli haiguse üle
English: COPD One inhalation of 50 micrograms salmeterol and 500 micrograms fluticasone propionate twice daily.
Estonian: Krooniline obstruktiivne kopsuhaigus (KOK) Üks inhalatsioon 50 mikrogrammi salmeterooli ja 500 mikrogrammi flutikasoonpropionaati kaks korda
English: There are no data available from clinical trials on overdose with Aerivio Spiromax, however data on overdose with both active substances are given below:
Estonian: Kliiniliste uuringute tulemustes andmed Aerivio Spiromax'i üleannustamise kohta puuduvad.
English: Posology
Estonian: Seonduvus
English: Uncommon (may affect up to 1 in 100 people)
Estonian: Aeg-ajalt (võib esineda kuni ühel inimesel 100-st)
English: Rounded (moon shaped) face (Cushing's syndrome) Your doctor will check you regularly for any of these side effects and make sure you are taking the lowest dose of this combination of drugs to control your asthma.
Estonian: Arst kontrollib teid regulaarselt nende kõrvaltoimete osas ja määrab selle ravimikombinatsiooni madalaima annuse, millega saab teie astmat kontrolli all hoida.
English: • Low levels of sugar in your blood
Estonian: • madal kaaliumisisaldus veres;
English: • Bruising and fractures.
Estonian: • oksendamine ja kõhulahtisus;
English: Interactions with other medicinal products
Estonian: RAVIMI VÄLJASTAMISTINGIMUSED
English: Patients should also be advised to rinse their mouth with water and spit the water out, and/or brush their teeth
Estonian: Patsientidele tuleb soovitada pärast inhaleerimist suud veega loputada ja loputusvesi välja sülitada ja/või hambaid pesta (vt lõik 4.4).
English: Fluticasone propionate:
Estonian: Salmeterolum / Fluticasoni propionas
English: - If you get any side effects, talk to your doctor pharmacist or nurse.
Estonian: - Kui teil tekib ükskõik milline kõrvaltoime, pidage nõu oma arsti, apteekri või meditsiiniõega.